GHIT invests in GeneDesign and DNDi partnership to develop a better treatment for cutaneous leishmaniasis

31 Mar 2016

The Global Health Innovative Technology Fund (GHIT Fund) has announced today that it will invest in innovative malaria eradication tools, a new diagnostic test for tuberculosis, and new treatments for cutaneous leishmaniasis and soil-transmitted helminthiasis infections.

GHIT awarded US$687,715 to a partnership between GeneDesign, Inc., a Japan-based biotech, and DNDi to develop a better treatment for cutaneous leishmaniasis. With GHIT’s investment, GeneDesign and DNDi will assess an immunomodulator with an anti-parasitic drug to enhance healing and parasite clearance of skin lesions. This proposed approach shows potential to work faster than current drugs, reduce scarring, and prevent relapse.

Read the press release by the GHIT Fund

Photo credit: Fabio Nascimento-DNDi

Read, watch, share

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

Get in touch

Support us

Work with us

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG	2 years	This cookie is installed by Google Analytics.
_gat_UA-10302561-1	1 minute	A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress	30 minutes	Hotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen	30 minutes	Hotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample	2 minutes	Hotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample	2 minutes	Hotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_1128844	30 minutes	Hotjar sets this cookie.
_hjSessionUser_1128844	1 year	Hotjar sets this cookie.
CONSENT	2 years	YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.

Targeting

GHIT invests in GeneDesign and DNDi partnership to develop a better treatment for cutaneous leishmaniasis

GHIT invests in GeneDesign and DNDi partnership to develop a better treatment for cutaneous leishmaniasis

Read, watch, share

Mark Sullivan joins the DNDi Scientific Advisory Committee

DNDi’s Centres of Excellence: Towards the sustainable elimination of visceral leishmaniasis in India

Biotech leader Delali Attiogbe Attipoe joins DNDi as North America Director

Africa should bolster research into climate-sensitive diseases

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

A drug development model for the diseases the world forgot

DNDi urges G20 to operationalize equity in response to major global health challenges and priorities

Certara and DNDi partnering to fast-track data submissions and accelerate drug approvals for neglected patients

Help neglected patients

Learn more

Get in touch

Support us

Work with us